Showing 591-600 of 1849 results for "".
Recent Developments
https://practicaldermatology.com/columns/recent-developments/news/20326/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/22066/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-12/23254/Currents
https://practicaldermatology.com/topics/practice-management/currents/21098/Bugs in DermatologyIntralesional Cryosurgery: A Novel Treatment for Keloid Scars
https://practicaldermatology.com/topics/general-topics/intralesional-cryosurgery-a-novel-treatment-for-keloid-scars/22933/Intralesional cryosurgery appears to allow for focused destruction of keloid scar tissue with minimal damage to the surface of the skin.Recent Developments
https://practicaldermatology.com/columns/recent-developments/news/21265/Acne and Rosacea Awareness: Clinician Perspectives
https://practicaldermatology.com/topics/acne-rosacea/acne-and-rosacea-awareness-clinician-perspectives/23927/Key ways to improve treatment outcomes for patients with rosacea and acne.Papa in at Valeant, J&J Acquires Neostrata, Celebrity Lip Envy
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-papa-in-at-valeant-j-j-acquires-neostrata-celebrity-lip-envy/18772/This edition of DermWireTV brings news that Joseph C. Papa has left Perrigo Company plc, a top five global over-the-counter consumer goods and pharmaceutical company, to take the helm as CEO at Valeant Pharmaceuticals. He will replace J. Micheal Pearson. Valeant also concluded its investigation arouExploring Patient-Reported Outcomes Measures in Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/exploring-patient-reported-outcomes-measures-in-atopic-dermatitis/23886/Patient-reported outcomes may solve some of the challenges with measuring the physical and psychosocial manifestations.Therapeutics Update: New products and pharmacologic developments
https://practicaldermatology.com/columns/new-products/therapeutics-update-new-products-and-pharmacologic-developments/20390/